Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (IS) (2016 - 2026)

Updated

Protagenic Therapeutics, Inc.new's Share-based Compensation (IS) was $62,409 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.1% from $105,868 a year earlier and down 6.9% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Share-based Compensation (IS) (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protagenic Therapeutics, Inc.new's Share-based Compensation (IS) was $360,416 through Sep 30, 2026, down 99.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $418,589.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,300.96 Bn 1,274.58 Bn 20.46 Bn -
2 Johnson & Johnson 691.57 Bn 611.43 Bn 17.30 Bn -
3 AbbVie 526.86 Bn 494.87 Bn 13.12 Bn -
4 Merck 365.17 Bn 328.11 Bn 13.19 Bn -
5 Novartis Ag 314.51 Bn 287.74 Bn - -
6 Astrazeneca 288.94 Bn 262.45 Bn 13.26 Bn -
7 Amgen 254.33 Bn 205.98 Bn 7.58 Bn -
8 Gilead Sciences 211.53 Bn 186.64 Bn 6.73 Bn -
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn -
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn - 62,409.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 62,409.00
Jun 30, 2026 67,012.00
Sep 30, 2025 105,868.00
Jun 30, 2025 125,127.00
Mar 31, 2017 483.30 Mn
Mar 31, 2016 1,000.00
API Access

Protagenic Therapeutics, Inc.new Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PTIX&period=max&api_key=YOUR_API_KEY